NEW STEP BY STEP MAP FOR ACTIVE PHARMACEUTICAL INGREDIENTS

“The existing problem has exposed some structural weaknesses during the EU’s medicines provide chain as well as a large dependence on non-EU international locations for active pharmaceutical ingredients,” Kyriakides stated. She encouraged that supply chain difficulties be dealt with in an EU pharmaceutical system predicted for being introduce

“The current situation has exposed some structural weaknesses in the EU’s medicines offer chain and a significant dependence on non-EU nations for active pharmaceutical ingredients,” Kyriakides mentioned. She advised that supply chain difficulties be tackled in an EU pharmaceutical strategy predicted being introduced by the tip on the year.�